NEUNEUREN PHARMACEUTICALS LIMITED

Investor presentation, 26 August 2026

Date and time
Announcement type
Financial Results

More from Health Care

RGTCompany Update29 September 2026

Argent BioPharma (ASX: RGT) Licences NLC Antiviral Portfolio

More News